Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling, Tinnitus
Clinical narrative: extreme fatigue; pain at the injection sight; cysts in my left breasts; herpes outbreak/spread to other parts of my body; simply felt overall unwell; deep itch; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Jan2022 at 09:30 as dose 3 (booster), single (Lot number: FJ1614) at the age of 46 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing); "I have herpes" (ongoing), notes: I have herpes that was under control for years. Concomitant medication(s) included: L-LYSINE [LYSINE]. Past drug history included: Albuterol, reaction(s): "Allergy". Vaccination history included: BNT162b2 (Lot number=EWO183, dose number=1, prev dose vaccine location=Left arm), administration date: 16May2021, when the patient was 45-year-old, for Covid-19 immunization; BNT162b2 (Lot number=EWO187, dose number=2, prev dose vaccine location=Left arm), administration date: 06Jun2021, when the patient was 45-year-old, for Covid-19 Immunization, reaction(s): "extreme fatigue", "headache". The following information was reported: BREAST CYST (non-serious) with onset 17Jan2022, outcome "not recovered", described as "cysts in my left breasts"; PRURITUS (non-serious) with onset 17Jan2022, outcome "not recovered", described as "deep itch"; FATIGUE (non-serious) with onset 17Jan2022, outcome "not recovered", described as "extreme fatigue"; HERPES VIRUS INFECTION (non-serious) with onset 17Jan2022, outcome "not recovered", described as "herpes outbreak/spread to other parts of my body"; VACCINATION SITE PAIN (non-serious) with onset 17Jan2022, outcome "not recovered", described as "pain at the injection sight"; MALAISE (non-serious) with onset 17Jan2022, outcome "not recovered", described as "simply felt overall unwell". The events "extreme fatigue", "pain at the injection sight", "cysts in my left breasts", "herpes outbreak/spread to other parts of my body", "simply felt overall unwell" and "deep itch" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of fatigue, vaccination site pain, breast cyst, herpes virus infection, malaise, pruritus. Additional information: The patient reported that no other vaccine in four weeks. Other medications in two weeks: Multivitamin and L-lysine. Adverse event: With the second dose patient had extreme fatigue for 6 months and a 28 day headache at the base of skull. After the booster (3rd dose) Patient suffered from ongoing extreme fatigue, a deep itch/pain at the injection sight, cysts in left breasts. patient have herpes that was under control for years. Less than 48 hours after the booster patient suffered an outbreak and have continued to have outbreaks (that have now spread to other parts of my body) every 10-14 days. All of the symptoms have remained ongoing even though it's been over 6 months. Patient simply felt overall unwell since receiving these vaccines. Patient is normally a very healthy, energetic and active woman. AE treatment: doctors visits, pt, supplements, red light therapy. Covid prior vaccination: No. Covid tested post vaccination: Yes. Covid test post vaccination: [{covid test type post vaccination=Nasal Swab, covid test name post vaccination=I've taken many at home tests and several PCR , covid test result=Negative}].